Center for Development of Advanced Medicine for Dementia


Department & Laboratories

Home > CAMD (Japanese) > CAMD > Department & Laboratories > Department of Clinical and Experimental Neuroimaging

Department of Clinical and Experimental Neuroimaging

Objectives and Roles

We research on early diagnosis, pathological investigation and determination of treatment effects for dementia and related diseases by using brain imaging technologies such as PET, SPECT, MEG, and MRI. We also aim to widely apply brain imaging technologies to the development of disease modifying drugs for dementia.

Summary of Research Activities

MEG (magnetoencephalography)

A technique that enables us to map brain activity by recording magnetic fields produced by changes in electrical activity occurring naturally in the neuronal networks.

Functional MRI (functional magnetic resonance imaging)

A procedure that measurers brain activity by detecting changes associated with blood flow in the brain.

PET and SPECT (positron emission tomography and single-photon emission computed tomography)

Procedures that enable us to evaluate brain activity or pathlogy as images. Although slightly different, the drugs used in each procedure are similar in the sense that they both use radiotracers specially designed for targets in the brain.


  • National Center for Geriatrics and Gerontology
  • National Hospital for Geriatric Medicine, NCGG
  • Research Institute, NCGG
  • Center for Gerontology and Social Science

National Center for Geriatrics and Gerontology

7-430 Morioka-cho, Obu City, Aichi Prefecture, Japan